In an interview with BBC Radio, Neil Ferguson said that older and middle-aged groups should receive the vaccine because the threat of coronavirus far outweighs the risk of clots, which affect only one in 600,000 people who have received vaccine (0.00017%).
However, the 53-year-old epidemiologist SAGE, who was also vaccinated with the AstraZeneca injection, said the balance of risk is “slightly more complicated” when young people are considered less vulnerable to the virus. The risk of blood clots with the vaccine may be higher in younger age groups.
“In terms of current data, there is growing evidence that there is a rare risk associated with blood clots, particularly with the AstraZeneca vaccine,” he said, stressing however that “the risk appears to be age-related.”
This means that, “the older a person is, the greater the risk of contracting Covid-19, which is why the risk-benefit equation really points to vaccination”. However, “it gets more complicated when we reach younger age groups, where the risk-benefit equation has to be evaluated, because they are less at risk of being infected”, he explains.
British scientists say the risk of dying from Covid-19 for people aged 25 to 44 is 0.04% and 0.01% for people aged 15 to 24. By comparison, the rate is up to 6% in elderly groups.
Get the latest news delivered to your inbox
Follow us on social media networks